Quest Diagnostics
DGX · NYSE
Bulios Fair Price
$338
43.8% upside
Current Price
$235.02
According to Bulios Fair Price, DGX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Quest Diagnostics Incorporated (DGX) is an American company that provides diagnostic information and services for healthcare. The company offers a wide range of laboratory tests and diagnostic services, including blood tests, genetic tests, tests for infectious diseases, and screening tests for disease prevention. With an extensive network of laboratories and partnerships with healthcare providers, Quest Diagnostics is one of the leading providers of diagnostic services in the United States. The company is known for its quality, reliability, and ability to provide comprehensive diagnostic information for physicians and patients. Quest Diagnostics Incorporated (DGX) shares could be suitable for investors looking to invest in companies providing healthcare services and diagnostic information with a strong market position and a good reputation in the healthcare industry.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
Employees
51,500
Headquarters
Secaucus
Upcoming events
Ex-Dividend
Ex-dividend date
Earnings
Upcoming earnings report
Dividend Payment
Payment date